Stocktoria
BIO-RAD LABORATORIES, INC. BIO
NYSE · XNYS · stock · Laboratory Analytical Instruments · website · IPO 1980-03-17
BIO-RAD LABORATORIES, INC. financials (annual, from 10-K)
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $2.6B | $2.6B | $2.7B | $2.8B | $2.9B |
| Gross profit | $1.3B | $1.4B | $1.4B | $1.6B | $1.6B |
| R&D expense | $275.6M | $295.9M | $247.4M | $256.9M | $260.6M |
| SG&A expense | $844.3M | $814.0M | $841.7M | $827.8M | $877.1M |
| Operating income | $47.2M | $269.0M | $337.8M | $482.6M | $500.3M |
| Interest expense | $49.0M | $48.9M | $49.4M | $38.1M | $1.6M |
| Income tax | $235.6M | -$498.3M | -$212.8M | -$1.1B | $1.2B |
| Net income | $759.9M | -$1.8B | -$637.3M | -$3.6B | $4.3B |
| EPS (diluted) | $27.85 | $-65.36 | $-21.82 | $-121.79 | $140.83 |
| Operating cash flow | $532.2M | $455.2M | $374.9M | $194.4M | $669.5M |
| Free cash flow | $374.6M | $289.6M | $218.2M | $81.6M | $535.7M |
| Cash & equivalents | $529.8M | $488.1M | $403.8M | $434.2M | $470.8M |
| Inventory | $740.7M | $760.0M | $780.5M | $719.3M | $572.2M |
| Total assets | $10.6B | $9.4B | $12.3B | $13.5B | $17.8B |
| Total liabilities | $3.1B | $2.8B | $3.6B | $3.9B | $4.1B |
| Shareholders' equity | $7.5B | $6.6B | $8.7B | $9.6B | $13.7B |
Source: SEC EDGAR filings · CIK 0000012208 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.